Ā | Initial CE | Follow-up CE | Pvalue |
---|---|---|---|
Polaprezinc group (nā=ā10) | Ā | Ā | Ā |
āMedian number of erosions/ulcers (range) | 2 (0-6) | 0 (0-4) | 0.039* |
āMedian number of reddened lesions (range) | 3 (0-7) | 1 (0-1) | 0.003* |
āMedian CE score (range) | 180 (0-450) | 0 (0-225) | N.S.* |
āCE score by category | Ā | Ā | Ā |
āNormal or clinical insignificant change (<135) | 3 | 6 | Ā |
āMild change (ā„135 and <790) | 7 | 4 | N.S.** |
āModerate or severe change (ā„790) | 0 | 0 | Ā |
Control group (nā=ā10) | Ā | Ā | Ā |
āMedian number of erosions/ulcers (range) | 2 (0-10) | 0 (0-9) | N.S.* |
āMedian number of reddened lesions (range) | 2 (0-7) | 2 (0-7) | N.S.* |
āMedian CE score (range) | 225 (0-225) | 0 (0-450) | N.S.* |
āCE score by category | Ā | Ā | Ā |
āNormal or clinically insignificant change (<135) | 4 | 6 | Ā |
āMild change (ā„135 and <790) | 6 | 4 | N.S.** |
āModerate or severe change ((ā„790) | 0 | 0 | Ā |